These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23867982)

  • 1. Tamoxifen improves cholinergically modulated cognitive performance in postmenopausal women.
    Newhouse P; Albert K; Astur R; Johnson J; Naylor M; Dumas J
    Neuropsychopharmacology; 2013 Dec; 38(13):2632-43. PubMed ID: 23867982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal postmenopausal women.
    Dumas J; Hancur-Bucci C; Naylor M; Sites C; Newhouse P
    Neuropsychopharmacology; 2006 Sep; 31(9):2065-78. PubMed ID: 16482084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: evidence for the critical period hypothesis.
    Dumas J; Hancur-Bucci C; Naylor M; Sites C; Newhouse P
    Horm Behav; 2008 Jan; 53(1):159-69. PubMed ID: 17964576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic versus muscarinic blockade alters verbal working memory-related brain activity in older women.
    Dumas JA; Saykin AJ; McDonald BC; McAllister TW; Hynes ML; Newhouse PA
    Am J Geriatr Psychiatry; 2008 Apr; 16(4):272-82. PubMed ID: 18378552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estradiol treatment in young postmenopausal women with self-reported cognitive complaints: Effects on cholinergic-mediated cognitive performance.
    Conley AC; Albert KM; McDonald BC; Saykin AJ; Dumas JA; Newhouse PA
    Hum Psychopharmacol; 2022 Sep; 37(5):e2838. PubMed ID: 35212023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine therapy is associated with low performance on some estrogen-sensitive cognitive tasks in postmenopausal women with breast cancer.
    Lejbak L; Vrbancic M; Crossley M
    J Clin Exp Neuropsychol; 2010 Oct; 32(8):836-46. PubMed ID: 20336566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic modulation of hippocampal activity during episodic memory encoding in postmenopausal women: a pilot study.
    Dumas JA; McDonald BC; Saykin AJ; McAllister TW; Hynes ML; West JD; Newhouse PA
    Menopause; 2010 Jul; 17(4):852-9. PubMed ID: 20616672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of medications with anticholinergic properties and cognitive function in a young-old community sample.
    Low LF; Anstey KJ; Sachdev P
    Int J Geriatr Psychiatry; 2009 Jun; 24(6):578-84. PubMed ID: 19021151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of anticholinergic use for the treatment of overactive bladder on cognitive function in postmenopausal women.
    Geller EJ; Crane AK; Wells EC; Robinson BL; Jannelli ML; Khandelwal CM; Connolly A; Parnell BA; Matthews CA; Dumond JB; Busby-Whitehead J
    Clin Drug Investig; 2012 Oct; 32(10):697-705. PubMed ID: 22873491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen treatment impairs cognitive performance after psychosocial stress and monoamine depletion in postmenopausal women.
    Newhouse PA; Dumas J; Wilkins H; Coderre E; Sites CK; Naylor M; Benkelfat C; Young SN
    Menopause; 2010 Jul; 17(4):860-73. PubMed ID: 20616673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups.
    Schlesinger C; Kamoi S; Ascher SM; Kendell M; Lage JM; Silverberg SG
    Int J Gynecol Pathol; 1998 Oct; 17(4):302-11. PubMed ID: 9785130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study.
    Kritz-Silverstein D; Von Mühlen D; Barrett-Connor E; Bressel MA
    Menopause; 2003; 10(3):196-202. PubMed ID: 12792289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive factors associated with adherence to oral antiestrogen therapy: results from the cognition in the study of tamoxifen and raloxifene (Co-STAR) study.
    Klepin HD; Geiger AM; Bandos H; Costantino JP; Rapp SR; Sink KM; Lawrence JA; Atkinson HH; Espeland MA
    Cancer Prev Res (Phila); 2014 Jan; 7(1):161-8. PubMed ID: 24253314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estradiol treatment altered anticholinergic-related brain activation during working memory in postmenopausal women.
    Dumas JA; Kutz AM; Naylor MR; Johnson JV; Newhouse PA
    Neuroimage; 2012 Apr; 60(2):1394-403. PubMed ID: 22266175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the antiestrogen tamoxifen on low-density lipoprotein concentrations and oxidation in postmenopausal women.
    Guetta V; Lush RM; Figg WD; Waclawiw MA; Cannon RO
    Am J Cardiol; 1995 Nov; 76(14):1072-3. PubMed ID: 7484866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive performance and cholinergic transmission: influence of muscarinic and nicotinic receptor blockade.
    Voss B; Thienel R; Reske M; Habel U; Kircher T
    Eur Arch Psychiatry Clin Neurosci; 2010 Nov; 260 Suppl 2():S106-10. PubMed ID: 20960003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia.
    Vinogradov S; Fisher M; Warm H; Holland C; Kirshner MA; Pollock BG
    Am J Psychiatry; 2009 Sep; 166(9):1055-62. PubMed ID: 19570929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen-cholinergic interactions: Implications for cognitive aging.
    Newhouse P; Dumas J
    Horm Behav; 2015 Aug; 74():173-85. PubMed ID: 26187712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: tamoxifen or radiotherapy?
    Viani GA; Bernardes da Silva LG; Stefano EJ
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e519-24. PubMed ID: 22704706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies.
    Klinkenberg I; Blokland A
    Neurosci Biobehav Rev; 2010 Jul; 34(8):1307-50. PubMed ID: 20398692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.